The Fda Bayesian Guidance

Media Summary: In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele deliver a quick reaction to Presentation Title: A Perspective Review of ... for me to present the reflection on the recent

The Fda Bayesian Guidance - Detailed Analysis & Overview

In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele deliver a quick reaction to Presentation Title: A Perspective Review of ... for me to present the reflection on the recent In this episode of "In the Interim…" guest host Cooper Berry moderates a detailed discussion on the evolution and practice of ... News coverage and slides used by speakers: As you're here on YouTube, you may want to watch "How Social Media Hacks Your Brain" ...

From Hypothesis Rejection to Belief Governance under ODP–DFP Stress For more than half a century, In this episode of "In the Interim...", Dr. Scott Berry hosts Dr. Stephen Senn, award-winning statistician and author, for a discussion ... In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele examine

Photo Gallery

The FDA Bayesian Guidance

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Reflection on the recent FDA Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Bayesian Statistics in Clinical trials The Past, Present, and Future

NISS-Merck Virtual Meet-up on Bayesian Statistics in Drug Development, April, 2020

Bayes theorem, P-values, Miracle Drugs, and the FDA

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 1

Charles Green: Bayesian Adaptive Trial Designs

BBIU | The FDA’s Bayesian Turn as Structural Reallocation of Epistemic Power

A Visit with Stephen Senn: Time, Concurrent Controls, and the Bayesian Guidance

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 2

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

View Detailed Profile

The FDA Bayesian Guidance

The FDA Bayesian Guidance

In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele deliver a quick reaction to

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Presentation Title: A Perspective Review of

Reflection on the recent FDA Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Reflection on the recent FDA Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

... for me to present the reflection on the recent

Bayesian Statistics in Clinical trials The Past, Present, and Future

Bayesian Statistics in Clinical trials The Past, Present, and Future

In this episode of "In the Interim…" guest host Cooper Berry moderates a detailed discussion on the evolution and practice of ...

NISS-Merck Virtual Meet-up on Bayesian Statistics in Drug Development, April, 2020

NISS-Merck Virtual Meet-up on Bayesian Statistics in Drug Development, April, 2020

News coverage and slides used by speakers: https://www.niss.org/news/

Bayes theorem, P-values, Miracle Drugs, and the FDA

Bayes theorem, P-values, Miracle Drugs, and the FDA

As you're here on YouTube, you may want to watch "How Social Media Hacks Your Brain" ...

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 1

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 1

On March 5, 2024,

Charles Green: Bayesian Adaptive Trial Designs

Charles Green: Bayesian Adaptive Trial Designs

... was a

BBIU | The FDA’s Bayesian Turn as Structural Reallocation of Epistemic Power

BBIU | The FDA’s Bayesian Turn as Structural Reallocation of Epistemic Power

From Hypothesis Rejection to Belief Governance under ODP–DFP Stress For more than half a century,

A Visit with Stephen Senn: Time, Concurrent Controls, and the Bayesian Guidance

A Visit with Stephen Senn: Time, Concurrent Controls, and the Bayesian Guidance

In this episode of "In the Interim...", Dr. Scott Berry hosts Dr. Stephen Senn, award-winning statistician and author, for a discussion ...

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 2

Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 2

On March 5, 2024,

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CBER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from

Bayesian Borrowing in Phase 3 Trials

Bayesian Borrowing in Phase 3 Trials

In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele examine